Daily Mail on MSN
Wonder pill shrinks tumours in a third of patients with six hard-to-treat cancers, early trial shows
An experimental pill can shrink tumours by nearly a third in six of the world's most difficult to treat cancers, early trial ...
SurvivorNet on MSN
A new type of immunotherapy drug showed striking results in hard-to-treat lung cancer, but more data is needed for US patients
A large clinical trial in China (HARMONi-6) found that a new immunotherapy drug, ivonescimab, may help patients with advanced ...
CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to reduce the likelihood that it will reach the dreaded "difficult-to-treat" stage ...
Patients treated with pembrolizumab plus paclitaxel with or without bevacizumab had a statistically significant and clinically meaningful improvement in PFS, regardless of PD-L1 status. Topline ...
A small proof-of-concept RCT found that tocilizumab, an IL-6 receptor blocker, showed a non-significant but clinically ...
Clinical assessment combined with musculoskeletal ultrasound examination revealed distinct phenotypes in difficult-to-treat psoriatic arthritis (PsA), with a greater inflammatory burden and more ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A promising new combination therapy is offering new hope for patients ...
MedPage Today on MSN
Tool Predicts Difficult-to-Treat Depression, Even Before Drug Failure
Novel scale shifts nomenclature away from "treatment resistant" depression ...
The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.
Please provide your email address to receive an email when new articles are posted on . In this Healio video, Philip J. Mease, MD, director of rheumatology research at Providence Swedish Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results